SB 75 – South DakotaStatus: Enacted
Year Introduced: 2018
Year Enacted: 2018
This bill would permit pharmacist dispensing prescription drug order for a biological product prescribed by its brand or proper name to select an interchangeable biological product of the prescribed product. Would prohibit pharmacist from dispensing an equivalent or interchangeable biological drug product if a brand name has been prescribed unless patient is informed of selection and given right of refusal. Would permit prescriber to prohbit a pharmacist from seecting an equivalent drug product or interchangeable biological product by handwriting on the prescription drug order, “brand necessary”.
Key Issues: PHARMACEUTICALS Biosimilar or Generic Competition
Return to Database Search
© 2018- The SLIHCQ Database. Initial funding for this project was provided by the Robert Wood Johnson Foundation. The views expressed here do not necessarily reflect the views of the Foundation.
No items found
Leave A Comment